Login / Signup

γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.

Jong Chul WonHyuk Sang KwonSeong Su MoonSung Wan ChunChong Hwa KimIe Byung ParkIn Joo KimJihyun LeeBong Yun ChaTae Sun Park
Published in: Diabetes & metabolism journal (2019)
GLA treatment in patients with painful DPN was noninferior to ALA in terms of reducing pain intensity measured by the VAS over 12 weeks.
Keyphrases
  • phase iii
  • placebo controlled
  • double blind
  • phase ii
  • open label
  • clinical trial
  • chronic pain
  • study protocol
  • type diabetes
  • pain management
  • randomized controlled trial
  • spinal cord
  • gestational age
  • replacement therapy